APGE (Apogee Therapeutics) Shares Buyback Ratio %: -26.44 (As of Aug. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APGE Apogee Therapeutics Inc APGE
22 GF Score
Price $134.74
! 3 Warning Signs
View Full Analysis

What is Apogee Therapeutics Shares Buyback Ratio %?

Apogee Therapeutics APGE -0.01% 22 Shares Buyback Ratio % is -26.44 as of Aug. 22, 2026. GuruFocus rates APGE with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Apogee Therapeutics's current shares buyback ratio was -26.44%.

Apogee Therapeutics Shares Buyback Ratio % Related Terms

Apogee Therapeutics Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Apogee Therapeutics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apogee Therapeutics Shares Buyback Ratio % Chart

Apogee Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Shares Buyback Ratio %
0.00 -1.90 -22.59 -15.00

Apogee Therapeutics Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.94 -13.72 -9.48 -0.61
APGE
22GF Score
Apogee Therapeutics Inc APGE
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apogee Therapeutics Shares Buyback Ratio % Calculation

Apogee Therapeutics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(59.479 - 68.401) / 59.479
=-15.00%

Apogee Therapeutics's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(74.882 - 75.339) / 74.882
=-0.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -26.44 mean?
Apogee Therapeutics (APGE) has a Shares Buyback Ratio % of -26.44 as of Aug. 22, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Apogee Therapeutics and its competitors.
Is Apogee Therapeutics' Shares Buyback Ratio % too high?
Apogee Therapeutics' current Shares Buyback Ratio % is -26.44. Overall, Apogee Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Apogee Therapeutics' Shares Buyback Ratio % compare to CORT and KRYS?
Apogee Therapeutics' Shares Buyback Ratio % of -26.44 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Biotechnology company?
A good Shares Buyback Ratio % depends on the Biotechnology industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Apogee Therapeutics and its competitors. Apogee Therapeutics's current Shares Buyback Ratio % is -26.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apogee Therapeutics stock overvalued right now?
Apogee Therapeutics (APGE) has a current Shares Buyback Ratio % of -26.44. The current Shares Buyback Ratio % is -26.44. Apogee Therapeutics' overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Apogee Therapeutics (APGE), the current Shares Buyback Ratio % is -26.44 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apogee Therapeutics Business Description

Address 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, USA, 02453
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
22GF Score

Get the complete analysis for APGE

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$134.74
Price